Product Information

TERIFLUNOMIDE 7 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2917 per EA under NDC 68462042330. Its NADAC has been published 118 times since May 22, 2024.

FDA first approved this application on Nov 15, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TERIFLUNOMIDE 7 MG TABLET

teriflunomide
$0.2917per EA

Strength

7 mg/1

NDC

68462042330

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TERIFLUNOMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209663

FDA Approved

11/15/2018

TE Code

AB

On Market Since

1/19/2023

Pharmacological Classes

Dihydroorotate Dehydrogenase Inhibitors
Pyrimidine Synthesis Inhibitor

Price Statistics

The NADAC for TERIFLUNOMIDE 7 MG TABLET has been published 118 times since May 22, 2024, and over the history we have for it it has declined 51.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2917 per EA
All-time high$0.6572 (Mar 11, 2026)
All-time low$0.2917 (Aug 19, 2026)
52-week high$0.6572
52-week low$0.2917
Median price$0.5460
Average price$0.5203
Largest weekly change-28.7% (May 20, 2026)
Weeks tracked118
Tracking sinceMay 22, 2024

Price History

1W

-1.8%

1M

-1.8%

3M

-10.6%

6M

-55.6%

1Y

-45.9%

3Y

N/A

5Y

N/A

All

-51.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of TERIFLUNOMIDE 7 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TERIFLUNOMIDE 7 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2917 per EA (NDC 68462042330), effective Aug 19, 2026.

How has the price of TERIFLUNOMIDE 7 MG TABLET changed over time?

Over the history we have for it, the NADAC for TERIFLUNOMIDE 7 MG TABLET has declined 51.8%. It has been tracked across 118 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for TERIFLUNOMIDE 7 MG TABLET?

Since May 22, 2024, the NADAC for TERIFLUNOMIDE 7 MG TABLET has ranged from a low of $0.2917 (Aug 19, 2026) to a high of $0.6572 (Mar 11, 2026), with a median of $0.5460 per EA.

Are there cheaper alternatives to TERIFLUNOMIDE 7 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TERIFLUNOMIDE 7 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TERIFLUNOMIDE 7 MG TABLET?

TERIFLUNOMIDE 7 MG TABLET (NDC 68462042330) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.